Gastroesophageal Reflux Disease Increases Risk for Atrial Fibrillation
By Lori Solomon HealthDay Reporter
TUESDAY, July 2, 2024 -- Gastroesophageal reflux disease (GERD) is associated with an increased incidence of atrial fibrillation, according to a study published online June 2 in Frontiers in Cardiovascular Medicine.
Lei Wang and Yi Wei Lu, from the Aerospace Center Hospital in Beijing, and colleagues assessed GERD’s role as a potential contributing factor in atrial fibrillation using a two-sample Mendelian randomization technique. The examination of the association of genetic variants with GERD used data from a genome-wide association study (GWAS) of 602,604 people, while data on the association between genetic variations and atrial fibrillation was obtained from a second GWAS involving 1.03 million participants.
The researchers found that Mendelian randomization analyses, using 76 single nucleotide polymorphisms as markers, revealed a relationship between genetically predicted GERD and a greater atrial fibrillation incidence (odds ratio, 1.165). There was no evidence of gene pleiotropy (intercept = 0.003). Similar results were seen in a sensitivity analysis.
"The Mendelian randomization analysis revealed a correlation between GERD and increased atrial fibrillation incidence, supporting the idea that treating patients with GERD as early as possible might reduce their chance of developing atrial fibrillation," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
Odds of IBS, Functional Dyspepsia Increased After Acute Gastroenteritis Episode
WEDNESDAY, July 17, 2024 -- A considerable proportion of individuals experiencing acute gastroenteritis develop postinfection irritable bowel syndrome (PI-IBS) and postinfection...
Pulsed Field Ablation Demonstrates Favorable Safety Profile for A-Fib
THURSDAY, July 11, 2024 -- For patients with atrial fibrillation (AF), pulsed field ablation (PFA) demonstrates a favorable safety profile, according to a study published online...
Study Compares Rivaroxaban, Warfarin With Apixaban for Cirrhosis, A-Fib
MONDAY, July 8, 2024 -- For patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.